{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:54:11Z","timestamp":1778824451030,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K08 HS026030-02"],"award-info":[{"award-number":["K08 HS026030-02"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1245\/s10434-020-08285-0","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:02:48Z","timestamp":1583175768000},"page":"2653-2663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Barriers and Facilitators to De-Implementation of the Choosing Wisely\u00ae Guidelines for Low-Value Breast Cancer Surgery"],"prefix":"10.1245","volume":"27","author":[{"given":"Margaret E.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Ann","family":"Vitous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasha M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah P.","family":"Shubeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reshma","family":"Jagsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesly A.","family":"Dossett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"8285_CR1","doi-asserted-by":"publisher","unstructured":"Institute of Medicine. Best care at lower cost: the path to continuously learning health care in America. Washington, DC: The National Academies Press; 2013. https:\/\/doi.org\/10.17226\/13444.","DOI":"10.17226\/13444"},{"key":"8285_CR2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jama.2018.0018","volume":"319","author":"SJ Katz","year":"2018","unstructured":"Katz SJ, Jagsi R, Morrow M. Reducing overtreatment of cancer with precision medicine: iust what the doctor ordered. JAMA. 2018;319:1091\u20132.","journal-title":"JAMA."},{"key":"8285_CR3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1470-2045(11)70141-3","volume":"12","author":"R Sullivan","year":"2011","unstructured":"Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12:933\u201380.","journal-title":"Lancet Oncol."},{"key":"8285_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bmjqs-2014-003821","volume":"24","author":"W Levinson","year":"2015","unstructured":"Levinson W, Kallewaard M, Bhatia RS, et al. \u2018Choosing Wisely\u2019: a growing international campaign. BMJ Qual Saf. 2015;24:167\u201374.","journal-title":"BMJ Qual Saf."},{"key":"8285_CR5","first-page":"697","volume":"44","author":"RS Bhatia","year":"2018","unstructured":"Bhatia RS, Kerr EA. Implementation of Choosing Wisely: promise and pitfalls. Jt Comm J Qual Patient Saf. 2018;44:697\u20138.","journal-title":"Jt Comm J Qual Patient Saf."},{"key":"8285_CR6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmjqs-2015-004070","volume":"24","author":"RS Bhatia","year":"2015","unstructured":"Bhatia RS, Levinson W, Shortt S, et al. Measuring the effect of Choosing Wisely: an integrated framework to assess campaign impact on low-value care. BMJ Qual Saf. 2015;24:523\u201331.","journal-title":"BMJ Qual Saf."},{"key":"8285_CR7","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.2012.476","volume":"307","author":"CK Cassel","year":"2012","unstructured":"Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307:1801\u20132.","journal-title":"JAMA."},{"key":"8285_CR8","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1377\/hlthaff.2017.0953","volume":"36","author":"EA Kerr","year":"2017","unstructured":"Kerr EA, Kullgren JT, Saini SD. Choosing Wisely: how to fulfill the promise in the next 5\u00a0years. Health Aff (Millwood). 2017;36:2012\u20138.","journal-title":"Health Aff (Millwood)."},{"key":"8285_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569\u201375.","journal-title":"JAMA."},{"key":"8285_CR10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297\u2013305.","journal-title":"Lancet Oncol."},{"key":"8285_CR11","first-page":"168","volume":"24","author":"A Weiss","year":"2017","unstructured":"Weiss A, Mittendorf E, DeSnyder S, et al. ACOSOG Z0011: impact after 5 years. Ann Surg Oncol. 2017;24:168\u20139.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR12","first-page":"17","volume":"21","author":"N Hodgson","year":"2014","unstructured":"Hodgson N, Cornacchi SD, Simunovic M, et al. ACOSOG Z0011 trial results: Led to marked changes in surgical treatment of the axilla among patients with breast cancer: a population-based study. Ann Surg Oncol. 2014;21:17\u20138.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR13","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.jamcollsurg.2015.07.030","volume":"221","author":"ER Berger","year":"2015","unstructured":"Berger ER, Yao K, Liederbach E, Winchester DP, Bilimoria KY. Are the ACOSOG Z011 findings being incorporated into practice nationally? An initial assessment of practice patterns in the US since publication of the trial results. J Am Coll Surg. 2015;221:S18.","journal-title":"J Am Coll Surg."},{"key":"8285_CR14","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","volume":"19","author":"AS Caudle","year":"2012","unstructured":"Caudle AS, Hunt KK, Tucker SL, et al. American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol. 2012;19:3144\u201351.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/tbj.12728","volume":"23","author":"MM Fillion","year":"2017","unstructured":"Fillion MM, Glass KE, Hayek J, et al. Healthcare costs reduced after iccorporating the results of the American College of Surgeons Oncology Group Z0011 trial into clinical practice. Breast J. 2017;23:275\u201381.","journal-title":"Breast J."},{"key":"8285_CR16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1377\/hlthaff.2015.1490","volume":"35","author":"DH Howard","year":"2016","unstructured":"Howard DH, Soulos PR, Chagpar AB, Mougalian S, Killelea B, Gross CP. Contrary to conventional wisdom, physicians abandoned a breast cancer treatment after a trial concluded it was ineffective. Health Aff (Millwood). 2016;35:1309\u201315.","journal-title":"Health Aff (Millwood)."},{"key":"8285_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/ajcp\/aqw078","volume":"146","author":"JM Jorns","year":"2016","unstructured":"Jorns JM, Kidwell KM. Sentinel lymph node frozen-section utilization declines after publication of American College of Surgeons Oncology Group Z0011 trial sesults with no change in subsequent surgery for axillary lymph node dissection. Am J Clin Pathol. 2016;146:57\u201366.","journal-title":"Am J Clin Pathol."},{"key":"8285_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.breast.2016.07.014","volume":"29","author":"VH Le","year":"2016","unstructured":"Le VH, Brant KN, Blackhurst DW, et al. The impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial: an institutional review. Breast. 2016;29:117\u20139.","journal-title":"Breast."},{"key":"8285_CR19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jsurg.2018.02.020","volume":"75","author":"NF Nocera","year":"2018","unstructured":"Nocera NF, Pyfer BJ, De La Cruz LM, Chatterjee A, Thiruchelvam PT, Fisher CS. NSQIP analysis of axillary lymph node dissection rates for breast cancer: implications for resident and fellow participation. J Surg Educ. 2018;75:1281\u20136.","journal-title":"J Surg Educ."},{"key":"8285_CR20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1245\/s10434-016-5516-5","volume":"24","author":"AM Schulman","year":"2017","unstructured":"Schulman AM, Mirrielees JA, Leverson G, Landercasper J, Greenberg C, Wilke LG. Reexcision surgery for breast cancer: an analysis of the American Society of Breast Surgeons (ASBrS) mastery(SM) database following the SSO-ASTRO \u201cno ink on tumor\u201d guidelines. Ann Surg Oncol. 2017;24:52\u20138.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaoncol.2017.0774","volume":"3","author":"M Morrow","year":"2017","unstructured":"Morrow M, Abrahamse P, Hofer TP, et al. Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. JAMA Oncol. 2017;3:1352\u20137.","journal-title":"JAMA Oncol."},{"key":"8285_CR22","first-page":"08","volume":"08","author":"L Havel","year":"2019","unstructured":"Havel L, Landercasper J. ASO author reflections: rapid uptake of the SSO ASTRO margin guideline and decreased reoperations after lumpectomy: a success story. Ann Surg Oncol. 2019;08:08.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jamcollsurg.2018.01.050","volume":"227","author":"N Bhutiani","year":"2018","unstructured":"Bhutiani N, Mercer MK, Bachman KC, et al. Evaluating the effect of margin consensus guideline publication on operative patterns and financial impact of breast cancer operation. J Am Coll Surg. 2018;227:6\u201311.","journal-title":"J Am Coll Surg."},{"key":"8285_CR24","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1245\/s10434-019-07247-5","volume":"26","author":"L Havel","year":"2019","unstructured":"Havel L, Naik H, Ramirez L, Morrow M, Landercasper J. Impact of the SSO-ASTRO margin guideline on rates of re-excision after lumpectomy for breast cancer: a meta-analysis. Ann Surg Oncol. 2019;26:1238\u201344.","journal-title":"Ann Surg Oncol."},{"issue":"504\u201312","key":"8285_CR25","first-page":"e2","volume":"228","author":"K Kaczmarski","year":"2019","unstructured":"Kaczmarski K, Wang P, Gilmore R, et al. Surgeon re-excision rates after breast-conserving surgery: a measure of low-value care. J Am Coll Surg. 2019;228:504\u201312 e2.","journal-title":"J Am Coll Surg."},{"key":"8285_CR26","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1200\/JCO.2010.29.4041","volume":"29","author":"TA King","year":"2011","unstructured":"King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29:2158\u201364.","journal-title":"J Clin Oncol."},{"key":"8285_CR27","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1245\/s10434-009-0641-z","volume":"16","author":"AK Arrington","year":"2009","unstructured":"Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697\u2013704.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","volume":"27","author":"TM Tuttle","year":"2009","unstructured":"Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362\u20137.","journal-title":"J Clin Oncol."},{"key":"8285_CR29","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1245\/s10434-009-0547-9","volume":"16","author":"NB Jones","year":"2009","unstructured":"Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691\u20136.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.2013.52.2284","volume":"32","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32:919\u201326.","journal-title":"J Clin Oncol."},{"key":"8285_CR31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.surge.2014.02.005","volume":"12","author":"A Soran","year":"2014","unstructured":"Soran A, Kamali Polat A, Johnson R, McGuire KP. Increasing trend of contralateral prophylactic mastectomy: what are the factors behind this phenomenon? Surgeon. 2014;12:316\u201322.","journal-title":"Surgeon."},{"key":"8285_CR32","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/PRS.0000000000001276","volume":"135","author":"CR Albornoz","year":"2015","unstructured":"Albornoz CR, Matros E, Lee CN, et al. Bilateral mastectomy versus breast-conserving surgery for early-stage breast cancer: the role of breast reconstruction. Plast Reconstr Surg. 2015;135:1518\u201326.","journal-title":"Plast Reconstr Surg."},{"key":"8285_CR33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10549-017-4528-6","volume":"167","author":"LS Dominici","year":"2018","unstructured":"Dominici LS, Sineshaw HM, Jemal A, Lin CC, King TA, Freedman RA. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt. Breast Cancer Res Treat. 2018;167:555\u201366.","journal-title":"Breast Cancer Res Treat."},{"key":"8285_CR34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.amjsurg.2015.11.005","volume":"211","author":"O Kantor","year":"2016","unstructured":"Kantor O, Pesce C, Liederbach E, Wang CH, Winchester DJ, Yao K. Surgery and hormone therapy trends in octogenarians with invasive breast cancer. Am J Surg. 2016;211:541\u20135.","journal-title":"Am J Surg."},{"key":"8285_CR35","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1245\/s10434-016-5368-z","volume":"23","author":"A Mamtani","year":"2016","unstructured":"Mamtani A, Gonzalez JJ, Neo D, et al. Early-stage breast cancer in the octogenarian: tumor characteristics, treatment choices, and clinical outcomes. Ann Surg Oncol. 2016;23:3371\u20138.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1467-9531.2011.01244.x","volume":"41","author":"DD Heckathorn","year":"2011","unstructured":"Heckathorn DD. Snowball versus respondent-driven sampling. Sociol Methodol. 2011;41:355\u201366.","journal-title":"Sociol Methodol."},{"key":"8285_CR37","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26:1753\u201360.","journal-title":"Qual Health Res."},{"key":"8285_CR38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","volume":"12","author":"L Atkins","year":"2017","unstructured":"Atkins L, Francis J, Islam R, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12:77.","journal-title":"Implement Sci."},{"key":"8285_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psych. 2006;3:77\u2013101.","journal-title":"Qual Res Psych."},{"issue":"1","key":"8285_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"GBA Guest","year":"2006","unstructured":"Guest G BA, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382.","journal-title":"Field Methods."},{"key":"8285_CR41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2013.11.012","volume":"88","author":"MS Moran","year":"2014","unstructured":"Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014;88:553\u201364.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"8285_CR42","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70\u00a0years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382\u20137.","journal-title":"J Clin Oncol."},{"key":"8285_CR43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/s10434-010-1217-7","volume":"18","author":"G Martelli","year":"2011","unstructured":"Martelli G, Miceli R, Daidone MG, et al. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15\u00a0years of follow-up. Ann Surg Oncol. 2011;18:125\u201333.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR44","doi-asserted-by":"crossref","unstructured":"Giuliano AE, Boolbol S, Degnim A, Kuerer H, Leitch AM, Morrow M. Society of Surgical Oncology: position statement on prophylactic mastectomy. approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol. 2007;14:2425\u20137.","DOI":"10.1245\/s10434-007-9447-z"},{"key":"8285_CR45","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/SLA.0000000000000769","volume":"260","author":"OM Fayanju","year":"2014","unstructured":"Fayanju OM, Stoll CR, Fowler S, Colditz GA, Margenthaler JA. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg. 2014;260:1000\u201310.","journal-title":"Ann Surg."},{"key":"8285_CR46","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1245\/s10434-015-4442-2","volume":"22","author":"PR Portschy","year":"2015","unstructured":"Portschy PR, Abbott AM, Burke EE, et al. Perceptions of contralateral breast cancer risk: a prospective, longitudinal study. Ann Surg Oncol. 2015;22:3846\u201352.","journal-title":"Ann Surg Oncol."},{"key":"8285_CR47","doi-asserted-by":"crossref","unstructured":"Portschy PR, Kuntz KM, Tuttle TM. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. J Natl Cancer Inst. 2014;106.","DOI":"10.1093\/jnci\/dju160"},{"key":"8285_CR48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci."},{"key":"8285_CR49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.2015.17949","volume":"315","author":"ES Fisher","year":"2016","unstructured":"Fisher ES, Shortell SM, Savitz LA. Implementation science: a potential catalyst for delivery system reform. JAMA. 2016;315:339\u201340.","journal-title":"JAMA."},{"key":"8285_CR50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38:65\u201376.","journal-title":"Adm Policy Ment Health."},{"key":"8285_CR51","volume-title":"Diffusion of innovations","author":"EM Rogers","year":"2003","unstructured":"Rogers EM.\u00a0Diffusion of innovations. New York: Free Press; 2003."},{"key":"8285_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-9-1","volume":"9","author":"V Prasad","year":"2014","unstructured":"Prasad V, Ioannidis JP. Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implement Sci. 2014;9:1.","journal-title":"Implement Sci."},{"key":"8285_CR53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12916-015-0488-z","volume":"13","author":"DJ Niven","year":"2015","unstructured":"Niven DJ, Mrklas KJ, Holodinsky JK, et al. Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC Med. 2015;13:255.","journal-title":"BMC Med."},{"key":"8285_CR54","doi-asserted-by":"crossref","unstructured":"Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH. Examining product risk in context. Market withdrawal of zomepirac as a case study. JAMA. 1993;270:1937\u201342.","DOI":"10.1001\/jama.1993.03510160055029"},{"key":"8285_CR55","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bmj.327.7419.845","volume":"327","author":"B Lawton","year":"2003","unstructured":"Lawton B, Rose S, McLeod D, Dowell A. Changes in use of hormone replacement therapy after the report from the Women\u2019s Health Initiative: cross sectional survey of users. BMJ. 2003;327:845\u20136.","journal-title":"BMJ."},{"key":"8285_CR56","first-page":"e265","volume":"23","author":"X Shen","year":"2017","unstructured":"Shen X, Stuart BC, Powers CA, Tom SE, Magder LS, Perfetto EM. Impact of formulary restrictions on medication use and costs. Am J Manag Care. 2017;23:e265-e74.","journal-title":"Am J Manag Care."},{"key":"8285_CR57","doi-asserted-by":"crossref","unstructured":"Prescott LS, Taylor JS, Enbaya A, et al. Choosing Wisely: decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol. 2019.","DOI":"10.1016\/j.ygyno.2019.03.008"},{"key":"8285_CR58","doi-asserted-by":"crossref","unstructured":"Voorn VMA, Marang-van de Mheen PJ, van der Hout A, et al. The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial. Implement Sci. 2017;12:72.","DOI":"10.1186\/s13012-017-0601-0"},{"key":"8285_CR59","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00198-016-3511-0","volume":"27","author":"EC Lasser","year":"2016","unstructured":"Lasser EC, Pfoh ER, Chang HY, et al. Has Choosing Wisely(R) affected rates of dual-energy X-ray absorptiometry use? Osteoporos Int. 2016;27:2311\u20136.","journal-title":"Osteoporos Int."},{"key":"8285_CR60","first-page":"e4002","volume":"11","author":"K Chandra","year":"2019","unstructured":"Chandra K, Atkinson PR, Chatur H, Fraser J, Adams CL. To choose or not to choose: evaluating the effect of a choosing wisely knowledge rranslation initiative for imaging in low back pain by bmergency physicians. Cureus. 2019;11:e4002.","journal-title":"Cureus."},{"key":"8285_CR61","doi-asserted-by":"crossref","first-page":"e183517","DOI":"10.1001\/jamanetworkopen.2018.3517","volume":"1","author":"PW Groeneveld","year":"2018","unstructured":"Groeneveld PW. Measuring and Improving the Value of Hospital Care. JAMA Netw Open. 2018;1:e183517.","journal-title":"JAMA Netw Open."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08285-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-020-08285-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08285-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:26:40Z","timestamp":1614644800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-020-08285-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["8285"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08285-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"17 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Dossett is supported by a grant from the Agency for Healthcare Research and Quality (AHRQ; 5 K08 HS026030-02). The authors have no conflicts of interest. Dr. Jagsi has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care companies; she has received personal fees from Amgen, Vizient and Sherinian and Hasso and grants for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the Koman Foundation and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}